Survey of hospitalization for respiratory syncytial virus in Nagano, Japan.

Published in: Pediatrics international : official journal of the Japan Pediatric Society (2018)

The rate of hospitalization for RSV was similar across each of the second-level hospitals in Nagano. Patients hospitalized after prophylactic palivizumab had received palivizumab only a few times during the season when infection rates were highest. Palivizumab is therefore advised prior to the outbreak initiation season.

Keyphrases

respiratory syncytial virus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
peritoneal dialysis
cross sectional
patient reported outcomes